Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of application.
 DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 22, 2018. Such persons may also file a written request for a hearing on the application on or before August 22, 2018.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register  Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on April 13, 2018, VHG Labs DBA LGC Standards, 3 Perimeter Road, Manchaster NH 03103 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance
Drug code
Schedule3-Fluoro-N-methylcathinone (3-FMC)
1233
ICathinone
1235
IMethcathinone
1237
I4-Fluoro-N-methylcathinone (4-FMC)
1238
IPentedrone (α-methylaminovalerophenone)
1246
IMephedrone (4-Methyl-N-methylcathinone)
1248
I4-Methyl-N-ethylcathinone (4-MEC)
1249
INaphyrone
1258
IN-Ethylamphetamine
1475
I4-Methylaminorex (cis isomer)
1590
IMethaqualone
2565
IJWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)
6250
ISR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole)
7008
IAPINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
7048
IJWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole)
7081
ISR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole
7104
IJWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)
7118
IJWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole)
7122
IUR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
7144
IAM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)
7201
IJWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole)
7203
IIbogaine
7260
ILysergic acid diethylamide
7315
I2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)
7348
IMarihuana
7360
IMescaline
7381
I2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 )
7385
I( print page 34876)4-Bromo-2,5-dimethoxyamphetamine
7391
I4-Bromo-2,5-dimethoxyphenethylamine
7392
IJWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole)
7398
I3,4-Methylenedioxyamphetamine
7400
IN-Hydroxy-3,4-methylenedioxyamphetamine
7402
I3,4-Methylenedioxy-N-ethylamphetamine
7404
I3,4-Methylenedioxymethamphetamine
7405
I4-Methoxyamphetamine
7411
I5-Methoxy-N-N-dimethyltryptamine
7431
IAlpha-methyltryptamine
7432
IBufotenine
7433
IDimethyltryptamine
7435
IPsilocyn
7438
IN-Benzylpiperazine
7493
I4-Methyl-alphapyrrolidinopropiophenone (4-MePPP)
7498
I2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E )
7509
I2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)
7518
I2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)
7519
IMDPV (3,4-Methylenedioxypyrovalerone)
7535
I2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe)
7537
IMethylone (3,4-Methylenedioxy-N-methylcathinone)
7540
IButylone
7541
IPentylone
7542
Ialpha-pyrrolidinopentiophenone (α-PVP)
7545
IAM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)
7694
ICodeine-N-oxide
9053
IDesomorphine
9055
IDihydromorphine
9145
IHeroin
9200
IMorphine-N-oxide
9307
INormorphine
9313
IPholcodine
9314
IDipipanone
9622
IProperidine
9644
ITilidine
9750
IAlpha-methylfentanyl
9814
IMethamphetamine
1105
IIPhenmetrazine
1631
IIAmobarbital
2125
IIPentobarbital
2270
IISecobarbital
2315
IIGlutethimide
2550
IIPhencyclidine
7471
IIPhenylacetone
8501
IIAlphaprodine
9010
IIDihydrocodeine
9120
IIDiphenoxylate
9170
IIEcgonine
9180
IIEthylmorphine
9190
IILevorphanol
9220
IIIsomethadone
9226
IIMeperidine
9230
IIMeperidine intermediate-B
9233
IIMeperidine intermediate-C
9234
IIDextropropoxyphene, bulk (non-dosage forms)
9273
II14-Hydroxmorphone
9665
IINoroxymorphone
9668
IIRemifentanil
9739
IISufentanil
9740
II
 The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substance. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a) (2). Authorization will not extend to the import of FDA approved or non- approved finished dosage forms for commercial sale. Dated: July 12, 2018. John J. Martin, Assistant Administrator.


[FR Doc. 2018-15721 Filed 7-20-18; 8:45 am] BILLING CODE 4410-09-P